Perceptive LIFE Sciences Master FUND Ltd. is 10% at XTL BIOPHARMACEUTICALS LTD (XTLB). They have made 105 open-market trades across 39 companies since 2005, most recently 2025-12-31.
CIK 0001249675
88 open-market purchases totalling $646.8M since 2005, against 17 sales. Across 72 scored buys the stock is down 0.9% at ninety days, and 2.1 points behind the S&P over the same stretch.
74 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 43% | 37% | 40% |
| Avg Move | -1.0% | -1.8% | -0.9% |
| Alpha | -2.7% | -2.0% | -2.1% |
| Scored | 74 | 73 | 72 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 67% | 60% | 29% |
| Avg Move | +2.6% | +6.5% | +42.5% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OBIO | BUY | 2025-08-01 | 2025-08-05 | $2.75 | $1.9M | -4.6% | +1.9% | +46.8% |
| ALDX | SELL | 2025-04-03 | 2025-04-07 | $1.42 | $4.8M | +6.8% | -2.0% | +112.2% |
| ACRV | BUY | 2024-04-11 | 2024-04-15 | $8.50 | $20.0M | -9.0% | -7.1% | -19.8% |
| ALDX | BUY | 2024-04-01 | 2024-04-03 | $3.84 | $3.8M | -8.8% | -8.8% | -28.7% |
| ALDX | SELL | 2023-10-16 | 2023-10-18 | $1.63 | $5.0M | -7.8% | +70.7% | +95.8% |
| ATXS | BUY | 2023-10-16 | 2023-10-18 | $6.51 | $14.0M | -15.6% | -21.6% | +30.5% |
| SLNO | BUY | 2023-05-30 | 2023-06-01 | $5.38 | $188K | -5.8% | -30.6% | -15.5% |
| MGTX | BUY | 2023-05-05 | 2023-05-15 | $5.75 | $50.0M | -2.6% | +17.6% | -7.9% |
| ATXS | BUY | 2022-12-19 | 2022-12-21 | $11.01 | $20.0M | +12.2% | +12.1% | -16.1% |
| CERE | BUY | 2022-08-16 | 2022-08-18 | $35.00 | $49.9M | -11.6% | -16.7% | -15.5% |
| ALDX | BUY | 2022-08-05 | 2022-08-09 | $6.95 | $980K | -8.3% | -12.7% | -29.7% |
| ALDX | BUY | 2022-08-03 | 2022-08-05 | $5.84 | $584K | +2.0% | -10.3% | -21.4% |
| ALDX | BUY | 2022-08-02 | 2022-08-04 | $5.59 | $4.6M | +22.5% | +3.3% | -11.3% |
| ALDX | BUY | 2022-07-28 | 2022-08-01 | $5.00 | $597K | +31.9% | +32.9% | +3.1% |
| VRCA | BUY | 2022-07-05 | 2022-07-05 | $2.10 | $6.0M | +22.1% | +20.5% | +13.7% |
| CRNX | BUY | 2022-04-18 | 2022-04-18 | $22.22 | $7.0M | -13.1% | -16.9% | -19.0% |
| NAUT | BUY | 2021-12-08 | 2021-12-10 | $5.36 | $1.1M | +14.4% | -8.0% | -24.7% |
| ADMA | SELL | 2021-08-17 | 2021-08-19 | $1.31 | $4.7M | +9.4% | +2.0% | +22.4% |
| VYNE | SELL | 2021-08-12 | 2021-08-16 | $2.23 | $1.5M | -12.6% | -14.9% | -26.4% |
| CERE | BUY | 2021-07-07 | 2021-07-09 | $25.00 | $5.0M | +3.1% | +7.6% | +38.3% |
| VBIV | SELL | 2021-06-29 | 2021-06-30 | $3.80 | $4.9M | -7.3% | -10.6% | -3.1% |
| NAUT | BUY | 2021-05-24 | 2021-06-11 | $10.00 | $55.1M | -16.6% | -7.7% | -31.0% |
| ARYA | BUY | 2021-05-20 | 2021-05-24 | $10.05 | $3.2M | -0.8% | N/A | N/A |
| ALDX | BUY | 2021-05-03 | 2021-05-04 | $12.50 | $15.0M | -4.4% | -1.7% | -29.0% |
| RAIN | BUY | 2021-04-27 | 2021-04-27 | $17.00 | $9.3M | +13.5% | +25.3% | +3.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| ZGNX | 4,070,357 | $108.6M |
| DOVA | 3,571,181 | $100.1M |
| MGTX | 10,231,103 | $95.0M |
| ALBO | 1,960,139 | $86.5M |
| RPRX | 1,362,560 | $83.1M |
| CORI | 6,074,686 | $77.0M |
| MNLO | 22,876,410 | $30.9M |
| VSAR | 4,134,547 | $29.5M |
| OBIO | 5,292,556 | $28.8M |
| LJPC | 3,734,470 | $23.2M |
| ATXS | 1,611,699 | $20.3M |
| NAUT | 9,111,151 | $18.8M |
| VRCA | 5,038,983 | $17.8M |
| LPTX | 8,476,496 | $17.4M |
| ATHA | 2,055,981 | $13.9M |
| AGRX | 14,919,925 | $9.0M |
| ACRV | 5,360,858 | $8.8M |
| SCYX | 1,833,849 | $6.6M |
| AEGR | 3,323,426 | $6.5M |
| QTNT | 16,200,818 | $6.2M |
| ALDX | 5,875,851 | $4.1M |
| ACRX | 4,533,728 | $3.9M |
| ATNX | 11,532,467 | $2.3M |
| ARYA | 159,925 | $1.8M |
| VBIV | 25,951,556 | $1.7M |
| LYRA | 1,934,115 | $957K |
| RAIN | 879,703 | $547K |
| MOTS | 1,800,541 | $312K |
| LIAN | 17,082 | $5K |
| OPTR | 123,686 | — |
| MACM.OB | 2,291,780 | — |
| XTLB | 57,092,850 | — |
| PPCO | 6,476,446 | — |
| Total | $2.6B |
Shares reported on the most recent Form 4, priced at the 2026-01-02 close. 4 holdings could not be priced and are excluded from the total.
| Scored | 15 | 15 | 14 |